Literature DB >> 22763467

A novel mutation I215V in the PRNP gene associated with Creutzfeldt-Jakob and Alzheimer's diseases in three patients with divergent clinical phenotypes.

Mercedes Muñoz-Nieto1, Neus Ramonet, Juan Ignacio López-Gastón, Natividad Cuadrado-Corrales, Olga Calero, Marcos Díaz-Hurtado, José Ramón Ipiens, Santiago Ramón y Cajal, Jesús de Pedro-Cuesta, Miguel Calero.   

Abstract

Genetic human prion diseases are autosomal dominant disorders associated with different mutations in the PRNP gene that are manifested as distinct clinical phenotypes. Here, we report a new pathogenic missense mutation (c.[643A>G], p.[I215V]) in the PRNP gene associated with three pathologically confirmed cases: two of Creutzfeldt-Jakob disease (CJD) and one of Alzheimer's disease (AD) in two different families from the same geographical region in Spain. This mutation has not been found in any of more than 2,000 control cases studied. It represents a conservative amino acid change, and the same change is observed in the PRNP gene from other species. The two CJD cases were homozygous at codon 129 (M/M), but showed divergent clinical phenotypes with onset at ages 55 and 77 years and illness durations of 15 and 6 months, respectively. The postmortem neuropathological analysis of these cases showed homogeneous features compatible with CJD. Interestingly, the AD case (a brother of one of the CJD cases) was heterozygous at codon 129 (M/V). No familiar history was documented for any of the cases, suggesting a de novo mutation, or a partial, age-dependent penetration of the mutation, perhaps related to codon 129 status. This new mutation extends the list of known pathogenic mutations responsible for genetic CJD, reinforces the clinical heterogeneity of the disease, and advocates for the inclusion of PRNP gene examination in the diagnostic workup of patients with poorly classifiable dementia, even in the absence of family history.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22763467     DOI: 10.1007/s00415-012-6588-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  48 in total

Review 1.  Mutation directional selection sheds light on prion pathogenesis.

Authors:  Liang Shen; Hong-Fang Ji
Journal:  Biochem Biophys Res Commun       Date:  2011-06-07       Impact factor: 3.575

2.  Genetic prion disease: the EUROCJD experience.

Authors:  Gábor G Kovács; Maria Puopolo; Anna Ladogana; Maurizio Pocchiari; Herbert Budka; Cornelia van Duijn; Steven J Collins; Alison Boyd; Antonio Giulivi; Mike Coulthart; Nicole Delasnerie-Laupretre; Jean Philippe Brandel; Inga Zerr; Hans A Kretzschmar; Jesus de Pedro-Cuesta; Miguel Calero-Lara; Markus Glatzel; Adriano Aguzzi; Matthew Bishop; Richard Knight; Girma Belay; Robert Will; Eva Mitrova
Journal:  Hum Genet       Date:  2005-11-15       Impact factor: 4.132

3.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

4.  NMR structure of the bovine prion protein.

Authors:  F López Garcia; R Zahn; R Riek; K Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

5.  Structural facets of disease-linked human prion protein mutants: a molecular dynamic study.

Authors:  Giulia Rossetti; Gabriele Giachin; Giuseppe Legname; Paolo Carloni
Journal:  Proteins       Date:  2010-12

6.  Prion protein NMR structures of elk and of mouse/elk hybrids.

Authors:  Alvar D Gossert; Sophie Bonjour; Dominikus A Lysek; Francesco Fiorito; Kurt Wüthrich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-12       Impact factor: 11.205

7.  A new bioinformatics analysis tools framework at EMBL-EBI.

Authors:  Mickael Goujon; Hamish McWilliam; Weizhong Li; Franck Valentin; Silvano Squizzato; Juri Paern; Rodrigo Lopez
Journal:  Nucleic Acids Res       Date:  2010-05-03       Impact factor: 16.971

8.  Prion protein NMR structure from tammar wallaby (Macropus eugenii) shows that the beta2-alpha2 loop is modulated by long-range sequence effects.

Authors:  Barbara Christen; Simone Hornemann; Fred F Damberger; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2009-04-23       Impact factor: 5.469

9.  Dynamic diagnosis of familial prion diseases supports the β2-α2 loop as a universal interference target.

Authors:  Massimiliano Meli; Maria Gasset; Giorgio Colombo
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

Review 10.  Basic mechanisms of neurodegeneration: a critical update.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

View more
  12 in total

Review 1.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

Review 2.  Neurological update: dementia.

Authors:  A J Larner
Journal:  J Neurol       Date:  2014-02-06       Impact factor: 4.849

Review 3.  Hereditary Human Prion Diseases: an Update.

Authors:  Matthias Schmitz; Kathrin Dittmar; Franc Llorens; Ellen Gelpi; Isidre Ferrer; Walter J Schulz-Schaeffer; Inga Zerr
Journal:  Mol Neurobiol       Date:  2016-06-20       Impact factor: 5.590

Review 4.  Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.

Authors:  Leonel T Takada; Mee-Ohk Kim; Ross W Cleveland; Katherine Wong; Sven A Forner; Ignacio Illán Gala; Jamie C Fong; Michael D Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-01       Impact factor: 3.568

5.  Prediction of disease genes using tissue-specified gene-gene network.

Authors:  Gamage Ganegoda; JianXin Wang; Fang-Xiang Wu; Min Li
Journal:  BMC Syst Biol       Date:  2014-10-22

6.  Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders.

Authors:  Jesús de Pedro-Cuesta; Pablo Martínez-Martín; Alberto Rábano; Enrique Alcalde-Cabero; Fernando José García López; Javier Almazán-Isla; María Ruiz-Tovar; Maria-José Medrano; Fuencisla Avellanal; Olga Calero; Miguel Calero
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

7.  Mutational analysis of PRNP in Alzheimer's disease and frontotemporal dementia in China.

Authors:  Weiwei Zhang; Bin Jiao; Tingting Xiao; Chuzheng Pan; Xixi Liu; Lin Zhou; Beisha Tang; Lu Shen
Journal:  Sci Rep       Date:  2016-12-02       Impact factor: 4.379

Review 8.  Additional mechanisms conferring genetic susceptibility to Alzheimer's disease.

Authors:  Miguel Calero; Alberto Gómez-Ramos; Olga Calero; Eduardo Soriano; Jesús Avila; Miguel Medina
Journal:  Front Cell Neurosci       Date:  2015-04-09       Impact factor: 5.505

9.  Lack of association of the M129V polymorphism of the PRNP gene with pseudoexfoliation syndrome.

Authors:  Marios P Giannakopoulos; Anna G Antonacopoulou; Anastasia E Kottorou; Haralabos P Kalofonos; Sotirios P Gartaganis
Journal:  Clin Ophthalmol       Date:  2016-04-22

Review 10.  Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases.

Authors:  Eva Bagyinszky; Vo Van Giau; Young Chul Youn; Seong Soo A An; SangYun Kim
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-14       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.